Dezhan Healthcare Company Limited
000813StockSHE
3.09 ▲ +1.31%
12 juin 2026
0
Dezhan Healthcare Company Limited
3.09 ▲ +1.31%
12 juin 2026
000813StockSHE

01 / À propos

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It also involved in the provision of biological peptides, industrial hemp, and medical service business. The company was founded in 1980 and is based in Beijing, the People's Republic of China.

Arberion
Loading market data